Third dose of the BNT162b2 vaccine results in very high levels of neutralizing antibodies against SARS-CoV-2: Results of a prospective study in 150 health professionals in Greece

希腊一项针对150名医护人员的前瞻性研究显示，接种第三剂BNT162b2疫苗后，体内产生了极高水平的针对SARS-CoV-2的中和抗体。